Etoposide for recurrent spinal cord ependymoma.
Chamberlain
Marc C
MC
Department of Neurology, USC/Norris Cancer Center, Los Angeles, CA 90033-0804, USA. chamberl@usc.edu
D000328:Adult; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004806:Ependymoma / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D005047:Etoposide / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D017567:Karnofsky Performance Status; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy* / Q000473:pathology; D013120:Spinal Cord Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery
D000972:Antineoplastic Agents, Phytogenic; D005047:Etoposide